New Risk • May 16
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 49% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (HK$452.0m market cap, or US$57.7m). Announcement • Apr 29
Maxnerva Technology Services Limited, Annual General Meeting, Jun 03, 2026 Maxnerva Technology Services Limited, Annual General Meeting, Jun 03, 2026, at 12:00 China Standard Time. Location: 303 hennessy road, wan chai, Hong Kong Reported Earnings • Mar 26
Full year 2025 earnings released: CN¥0.021 loss per share (vs CN¥0.018 loss in FY 2024) Full year 2025 results: CN¥0.021 loss per share (further deteriorated from CN¥0.018 loss in FY 2024). Revenue: CN¥707.6m (up 27% from FY 2024). Net loss: CN¥14.6m (loss widened 17% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Announcement • Mar 11
Maxnerva Technology Services Limited to Report Fiscal Year 2025 Results on Mar 25, 2026 Maxnerva Technology Services Limited announced that they will report fiscal year 2025 results on Mar 25, 2026 New Risk • Sep 22
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 38% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (38% average weekly change). Earnings have declined by 42% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (HK$435.0m market cap, or US$56.0m). Buy Or Sell Opportunity • Sep 01
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 10% to HK$0.26. The fair value is estimated to be HK$0.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 12% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Aug 23
First half 2025 earnings released: CN¥0.003 loss per share (vs CN¥0.023 loss in 1H 2024) First half 2025 results: CN¥0.003 loss per share (improved from CN¥0.023 loss in 1H 2024). Revenue: CN¥342.1m (up 32% from 1H 2024). Net loss: CN¥2.38m (loss narrowed 85% from 1H 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Announcement • Aug 09
Maxnerva Technology Services Limited to Report First Half, 2025 Results on Aug 20, 2025 Maxnerva Technology Services Limited announced that they will report first half, 2025 results on Aug 20, 2025 Reported Earnings • May 04
Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023) Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 91 percentage points per year, which is a significant difference in performance. Announcement • Apr 28
Maxnerva Technology Services Limited, Annual General Meeting, May 21, 2025 Maxnerva Technology Services Limited, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: 2/f., j plus, 35-45b bonham strand, sheung wan, Hong Kong Reported Earnings • Mar 30
Full year 2024 earnings released: CN¥0.018 loss per share (vs CN¥0.024 loss in FY 2023) Full year 2024 results: CN¥0.018 loss per share (improved from CN¥0.024 loss in FY 2023). Revenue: CN¥558.9m (down 18% from FY 2023). Net loss: CN¥12.4m (loss narrowed 26% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Announcement • Mar 13
Maxnerva Technology Services Limited to Report Fiscal Year 2024 Results on Mar 27, 2025 Maxnerva Technology Services Limited announced that they will report fiscal year 2024 results on Mar 27, 2025 Announcement • Jan 08
Maxnerva Technology Services Limited Appoints Huang Pi- Chun as Member of the Nomination Committee The board of directors of Maxnerva Technology Services Limited announce that Ms. Huang Pi- Chun, a non-executive Director of the Company, has been appointed as a member of the nomination committee effective from 8 January 2025. New Risk • Sep 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Hong Kong stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$100m (HK$214.0m market cap, or US$27.5m). Reported Earnings • Aug 26
First half 2024 earnings released: CN¥0.023 loss per share (vs CN¥0.008 profit in 1H 2023) First half 2024 results: CN¥0.023 loss per share (down from CN¥0.008 profit in 1H 2023). Revenue: CN¥258.9m (down 27% from 1H 2023). Net loss: CN¥16.2m (down 384% from profit in 1H 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. New Risk • Aug 22
New major risk - Revenue and earnings growth Earnings have declined by 26% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 26% per year over the past 5 years. Minor Risk Market cap is less than US$100m (HK$164.9m market cap, or US$21.2m). Announcement • Aug 21
Maxnerva Technology Services Limited Announces Directorate Changes The board (the "Board") of directors of Maxnerva Technology Services Limited (the " Company " and together with its subsidiaries, the "Group") announces that Mr. KUNG Pei-Yuan ("Mr. Kung") has tendered his resignation as non-executive Director with effect from 21 August 2024 due to his other business commitment. Mr. Kung has confirmed that he has no disagreement with the Board and there is nothing needed to be brought to the attention to the shareholders of the Company in relation to his resignation. On the same date, the Board has appointed Mr. CHANG Kuo-Chin ("Mr. Chang") as non-executive Director with effect from 21 August 2024. Mr. Chang, 56 years old, has over 30 years of extensive experience in the information technology field. He joined Hon Hai Precision Industry Co. Ltd. ("Hon Hai," along with its subsidiaries and affiliated companies, collectively referred to as the "Hon Hai Technology Group") in 1998. Hon Hai's shares are listed on the Taiwan Stock Exchange under stock code 2317. Mr. Chang specializes in information management, digital service platform establishment, and business operations. He currently serves as the senior assistant vice president and Head of the Central Information Department of Hon Hai Technology Group. Mr. Chang obtained his Bachelor's degree in Applied Mathematics from Chung Yuan Christian University in 1992 and worked in the IT department of Kuozui Motors Ltd. for three years.
From 1999 to 2020, Mr. Chang led the Information Division of J Business Group at Hon Hai Technology Group, where he planned and established various central digital platforms and laid the digital operational management foundation for the rapid growth of Hon Hai Technology Group. In 2016, he founded MinMax Technology (Shenzhen) Co. Ltd. and served as Chairman until 2023, demonstrating his visionary foresight and exceptional management capabilities. Since 2013, Mr. Chang has held the positions of chairman of Futaihong Precision Component (Shenzhen) Co. Ltd., and executive director of Fuchin Precision Industry (Shenzhen) Co. Ltd. Additionally, Mr. Chang was honored as one of Hon Hai Group 's Top 10 Inventors in both 2018 and 2020. Announcement • Aug 07
Maxnerva Technology Services Limited to Report Q2, 2024 Results on Aug 21, 2024 Maxnerva Technology Services Limited announced that they will report Q2, 2024 results on Aug 21, 2024 Buy Or Sell Opportunity • May 09
Now 21% undervalued Over the last 90 days, the stock has risen 21% to HK$0.28. The fair value is estimated to be HK$0.35, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company became loss making. Announcement • May 01
Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024 Maxnerva Technology Services Limited, Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: 2/F., J Plus,35-45B Bonham Strand Sheung Wan Hong Kong Agenda: To receive and adopt the audited financial statements and the reports of the directors and independent auditors of the Company for the year ended 31 December 2023; to re-appoint PricewaterhouseCoopers as auditors and to authorize the board of directors to fix their remuneration; to consider re-election of director and to fix the Directors' remuneration; and to consider other business issues. New Risk • Apr 24
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Hong Kong stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (15% average weekly change). Minor Risk Market cap is less than US$100m (HK$175.4m market cap, or US$22.4m). Buy Or Sell Opportunity • Apr 23
Now 27% undervalued Over the last 90 days, the stock has risen 39% to HK$0.25. The fair value is estimated to be HK$0.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Mar 28
Full year 2023 earnings released: CN¥0.024 loss per share (vs CN¥0.04 profit in FY 2022) Full year 2023 results: CN¥0.024 loss per share (down from CN¥0.04 profit in FY 2022). Revenue: CN¥677.9m (down 19% from FY 2022). Net loss: CN¥16.8m (down 161% from profit in FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year whereas the company’s share price has fallen by 20% per year. Announcement • Mar 13
Maxnerva Technology Services Limited to Report Fiscal Year 2023 Results on Mar 26, 2024 Maxnerva Technology Services Limited announced that they will report fiscal year 2023 results on Mar 26, 2024 Announcement • Sep 29
Maxnerva Technology Services Limited Announces Board Changes The board of directors of Maxnerva Technology Services Limited announced that Mr. TANG Tin Lok, Stephen (Mr. Tang) has tendered his resignation as independent non-executive Director with effect from 28 September 2023 due to his other business commitment. Mr. Tang has confirmed that he has no disagreement with the board and there is nothing needed to be brought to the attention to the shareholders of the company in relation to his resignation. On the same date, the board has appointed Mr. KAM Chi Sing (Mr. Kam) as independent non-executive director with effect from 28 September 2023. Mr. Kam, aged 52, has over 22 years of experience in management accounting, auditing and assurance, taxation, corporate services and cross border merger and acquisition consultation in Hong Kong and China. Mr. Kam established Roger Kam & Co., a certified public accounting firm in Hong Kong, in May 2000, and R&T Consulting Group Limited (R&T Consulting), a business consulting firm in Hong Kong, in July 2009. Mr. Kam is currently serving as the managing partner at Roger Kam & Co, the managing director at R&T Consulting and the chief representative of the representative offices of Roger Kam & Co in Shanghai, Guangzhou and Beijing. Mr. Kam has been acting as an independent non-executive director of Excellence Commercial Property & Facilities Management Group Limited since 28 September 2020 and LX Technology Group Limited since 27 September 2022 and a company secretary of Xinji Shaxi Group Co. Ltd. since 11 March 2019, all of which are listed on the Main Board of the Stock Exchange of Hong Kong Limited. Mr. Kam is a founding member of the Alliance of Inter-Continental Accountants and has been registered as a certified tax adviser and a chartered tax adviser by the Taxation Institute of Hong Kong since 2011 and 2020, respectively. He was admitted as a fellow member of the Association of Chartered Certified Accountants in November 2003, a fellow member of the Hong Kong Institute of Certified Public Accountants in April 2006, a fellow member of the Institute of Financial Accountants in March 2011, a fellow member of the Taxation Institute of Hong Kong in January 2010, a member of the Society of Trust and Estate Practitioners in April 2012 and a member of the Hong Kong Securities and Investment Institute in June 2013, respectively. He is a committee member of the taxation committee, a committee member of the financial and treasury services committee and a committee member of the China committee of Hong Kong General Chamber of Commerce. He has also been serving as a committee member of the Chinese General Chamber of Commerce, Hong Kong since November 2016. Mr. Kam was appointed as a member and honorary treasurer of Hong Kong Red Cross Special Education & Rehabilitation Service Governing Committee in November 2013, and school manager and treasurer of the Incorporated Management Committee of Hong Kong Red Cross Princess Alexandra Schools in July 2020. Mr. Kam obtained his bachelor's degree of science from the University of Hong Kong in November 1993. The board further announced that Mr. Kam has been appointed as the chairman of the Audit Committee of the Board, and a member of Nomination Committee and Remuneration Committee of the Board with effect from 28 September 2023. Reported Earnings • Aug 31
First half 2023 earnings released: EPS: CN¥0.008 (vs CN¥0.009 in 1H 2022) First half 2023 results: EPS: CN¥0.008 (down from CN¥0.009 in 1H 2022). Revenue: CN¥353.8m (down 1.4% from 1H 2022). Net income: CN¥5.70m (down 10% from 1H 2022). Profit margin: 1.6% (down from 1.8% in 1H 2022). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Announcement • Aug 15
Maxnerva Technology Services Limited to Report First Half, 2023 Results on Aug 28, 2023 Maxnerva Technology Services Limited announced that they will report first half, 2023 results on Aug 28, 2023 Reported Earnings • Mar 30
Full year 2022 earnings released: EPS: CN¥0.04 (vs CN¥0.05 in FY 2021) Full year 2022 results: EPS: CN¥0.04 (down from CN¥0.05 in FY 2021). Revenue: CN¥832.5m (up 40% from FY 2021). Net income: CN¥27.8m (down 19% from FY 2021). Profit margin: 3.3% (down from 5.7% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non Executive Director Xiaoquan Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 01
First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021) First half 2022 results: EPS: CN¥0.009 (down from CN¥0.017 in 1H 2021). Revenue: CN¥359.0m (up 39% from 1H 2021). Net income: CN¥6.34m (down 45% from 1H 2021). Profit margin: 1.8% (down from 4.4% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 21% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 28
First half 2022 earnings released: EPS: CN¥0.009 (vs CN¥0.017 in 1H 2021) First half 2022 results: EPS: CN¥0.009 (down from CN¥0.017 in 1H 2021). Revenue: CN¥359.0m (up 39% from 1H 2021). Net income: CN¥6.34m (down 45% from 1H 2021). Profit margin: 1.8% (down from 4.4% in 1H 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Announcement • Aug 18
Maxnerva Technology Services Limited Provides Earnings Guidance for the Six Months Ended 30 June 2022 Maxnerva Technology Services Limited provided earnings guidance for the six months ended 30 June 2022. For the period, the Group expects to record a consolidated net profit ranging from approximately RMB 5 million to RMB 7 million as compared to approximately RMB 11.5 million in the first half of 2021. Announcement • Aug 13
Maxnerva Technology Services Limited to Report Q2, 2022 Results on Aug 26, 2022 Maxnerva Technology Services Limited announced that they will report Q2, 2022 results on Aug 26, 2022 Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Non Executive Director Xiaoquan Zhang was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Mar 30
Full year 2021 earnings released: EPS: CN¥0.05 (vs CN¥0.022 in FY 2020) Full year 2021 results: EPS: CN¥0.05 (up from CN¥0.022 in FY 2020). Revenue: CN¥596.3m (up 14% from FY 2020). Net income: CN¥34.3m (up 134% from FY 2020). Profit margin: 5.7% (up from 2.8% in FY 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Reported Earnings • Sep 22
First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020) The company reported a solid first half result with improved earnings and profit margins, although revenues were flat. First half 2021 results: Revenue: CN¥258.5m (flat on 1H 2020). Net income: CN¥11.5m (up 18% from 1H 2020). Profit margin: 4.4% (up from 3.8% in 1H 2020). Reported Earnings • Aug 23
First half 2021 earnings released: EPS CN¥0.017 (vs CN¥0.015 in 1H 2020) The company reported a solid first half result with improved earnings and profit margins, although revenues were flat. First half 2021 results: Revenue: CN¥258.5m (flat on 1H 2020). Net income: CN¥11.5m (up 18% from 1H 2020). Profit margin: 4.4% (up from 3.8% in 1H 2020). Executive Departure • Apr 07
Non-Executive Director has left the company On the 31st of March, Eui Jong Jeon's tenure as Non-Executive Director ended after 2.0 years in the role. We don't have any record of a personal shareholding under Eui Jong's name. A total of 2 executives have left over the last 12 months. Reported Earnings • Apr 02
Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.018 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥523.4m (up 21% from FY 2019). Net income: CN¥14.6m (up 26% from FY 2019). Profit margin: 2.8% (up from 2.7% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Announcement • Mar 20
Maxnerva Technology Services Limited to Report Fiscal Year 2020 Results on Mar 31, 2021 Maxnerva Technology Services Limited announced that they will report fiscal year 2020 results on Mar 31, 2021 Is New 90 Day High Low • Feb 05
New 90-day high: HK$0.90 The company is up 58% from its price of HK$0.57 on 06 November 2020. The Hong Kong market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 29% over the same period. Is New 90 Day High Low • Jan 14
New 90-day high: HK$0.65 The company is up 5.0% from its price of HK$0.62 on 16 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 8.0% over the same period. Is New 90 Day High Low • Oct 05
New 90-day high: HK$0.47 The company is up 55% from its price of HK$0.30 on 07 July 2020. The Hong Kong market is down 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the IT industry, which is up 16% over the same period.